FDA Inspection 1122735 — Dompe Farmaceutici S.P.A.
The FDA completed an inspection of Dompe Farmaceutici S.P.A. on Feb 19, 2020 in Milan. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 19, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Milan (Italy)
Additional details
Postmarket Adverse Drug Experience (PADE)